Execs Could Boost Profits by Owning Health Care
Judging by their apathy over fixing the health care cost problem, C-suiters apparently are comfortable the way things are, a health care executive says.
Buybacks on Pace to Hit Record Level in 2019
The buyback boom is raising concerns as companies are returning more cash to shareholders than they are generating in free cash flow.
S&P Cuts Oracle Rating on Stock Buyback Worries
With Oracle's buybacks exceeding free operating cash-flow generation, S&P is concerned the company will be overleveraged.
Buybacks: Is Reform Overdue?
Regulators are asking who is ultimately benefiting from share repurchases.
Could This Be the Recession That Wasn’t?
Even as key corporate financial indicators continue to fall, some hope may be emerging that forecasts of an impending recession will prove inaccurate.
Mizuho Fined Over Handling of Buyback Orders
The SEC says the bank failed to prevent nonpublic information about clients' stock buybacks from being disclosed to other traders and hedge fund clients.
Is Exxon Riding Slowly into the Sunset?
If oil prices remain at current levels, at some point bond investors may no longer be willing to support the shrinking enterprise.
Repatriated Cash Should Boost R&D Spending
The new tax break on repatriated foreign earnings will spur increased R&D, a study of an earlier tax holiday suggests.
Markets Fairly Grade Share Buybacks
Instead of debating whether to ban share repurchases, we should focus on how to exclude the impact of buybacks from executive compensation.
SEC Gets Back to Full Five-Member Strength
The commission will no longer be short-handed after the Senate confirms the appointments of Robert Jackson and Hester Peirce.
Is Now the Time to Be Buying Back Shares?
CFOs have to ask themselves if share repurchases are really creating value.